Auna

AUNA

Market cap $368M

Auna S.A. ( AUNA ) Q3 2025 Earnings Call November 21, 2025 8:00 AM EST Company Participants Ana Maria Mora Jesús Zamora Leon - President, CEO & Executive Chairman of the Board Gisele Ferrero - CFO & Executive VP Conference Call Participants Mauricio Cepeda - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to Auna's Third Quarter 2025 Earnings Conference Call. My name is Eric and I'll be the operator for today's call.

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 (“third quarter 2025” or “3Q25”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q25 Consolidated Highlights Consoli.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America (“Sojitz”), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region's la.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru's Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership (“PPP”). When completed, Torre Trecca is.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today the closing of a US$765 million debt refinancing that significantly strengthens its capital structure by extending debt maturities, lowering interest expenses, and improving cash flow generation to further invest in the Company's various strategic growth initiatives. The Company and Oncosalud S.A.C., as co-issuer.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal amount of 8.750% Senior Secured Notes due 2032 (the “Notes”) to be issued by the Company and Oncosalud S.A.C. (“Oncosalud” and, together with the Company, the “Co-Issuers”), as co-issuers, which includes (i) U.S.$328,500,000 in aggregate principal amount of Notes offere.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA), a public limited liability company (société anonyme) incorporated and existing under the laws of Luxembourg, having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B267590 (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the e.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2025 financial results. Earnings Release Thursday, November 20, 2025 Time: After Market Close Conference Call Friday, November 21, 2025 Time: 8:00 a.m. ET Quiet Period Thursday, November 13 through Thursday, November 20, 2025 To participate, please dial.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that the Company and Oncosalud S.A.C. (“Oncosalud” and, together with the Company, the “Co-Issuers”), as co-issuers, intend to offer senior secured notes (the “Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”),.

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA), a public limited liability company (société anonyme) incorporated and existing under the laws of Luxembourg, having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B267590 (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the c.